Accumulating evidence suggests that inflammasomes such as NLRP3 inflammasome and AIM2 inflammasome contribute to the pathogenesis of AAA, a chronic inflammatory disease, and are considered promising targets to prevent or treat this disease. This evidence concerns the gene AIM2 and triple-A syndrome.